Solubility and dissolution improvement of ketoprofen by solid dispersion in polymer and surfactant using solvent evaporation method

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 4, 2011, Pages 431-435

  Khaleel, Nashwan Y ^a   Abdulrasool, Alaa A ^a   Ghareebowafaq, Moafaq M ^a   Hussain, Shad A ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Dissolution; Ketoprofen; Solid dispersion; Solubility

Indexed keywords

DRUG CARRIER; KETOPROFEN; MANNITOL; POLYMER; POLYSORBATE 80; UREA;

ARTICLE; CALORIMETRY; CHEMICAL INTERACTION; DISPERSION; DRUG COATING; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY;

EID: 80054857384     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kantor TG. Ketoprofen: A review of its pharmacologic and clinical properties. Pharmacotherapy 1986; 6:93-103.
2. Naidu NB, Chowdary KP, Murthy KV, Satyanarayana V, Hayman AR, and Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J Pharm Biomed Anal 2004; 35(1):75-86.
3. Vijaya Kumar SG, and Mishra DN. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi 2006; 126(2):93-97.
4. Vijaya Kumar SG, and Mishra DN. Preparation, characterization and in vitro dissolution of solid dispersion of meloxicam with PEG6000. Yakugaku Zasshi 2006; 126(8):657-664.
5. Margarit MV, Rodriguez IC, and Cerezo A. Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen on polyethylene glycol 6000. Int J Pharm 1994; 108:101-107.
6. Roger JA, and Anderson AJ. Physical characteristic and dissolution profiles of ketoprofen-urea solid dispersion. Pharm Acta Hely 1982; 57:276-282.
7. Sheen PC, Khetarpal VK, Cariola MC, and Rowlings CE. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int J Pharm 1995; 118:221-227.
8. Takayama K, Nambu N, and Nagai T. Factors affecting the dissolution of ketoprofen from solid dispersions in various water soluble polymers. Chem Pharm Bull 1982; 3:3013-3019.
9. El-Badry M, and Fathy M. Enhancement of the dissolution and permeation rate of meloxicam by formulation of its freeze dried solid dispersion in PVPK-30. Drug Dev Ind Pharm 2006; 32:141-150.
10. Adrian WC, and Brain BW. Penetration enhancer. Adv Drug Del Rev 2004; 56:603-618.
11. Ahuja N, Katare OP, and Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007; 65(1):26-38.
12. Punitha S, Vedha Hari BN, and Karthikeyan D. Enhancement of celecoxib solubility by solid dispersion using mannitol. Int J Pharmacy Pharma Sci 2010; 2(4):109-111.
13. Cirri M, Mura P, Rabasco AM, Gines JM, Moyano JR, and Gonzalez-Rodriguez ML. Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev Ind Pharm 2004; 30:65-74.
14. Vippagunta SR, Maul KA, Tallavajhala S, and Grant DJW. Solid-state characterization of nifedipine solid dispersions. Int J Pharm 2002; 236:111-123.
15. Chiou WL, and Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971; 60:1281-1302.
16. Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975; 27:48-49.
17. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969; 58:1253-1257.
18. Gibaldi M, and Feldman S. Establishment of sink conditions in dissolution rate determinations: theoretical considerations and application to non-disintegrating dosage forms. J Pharm Sci 1967; 56:1238-1242.
19. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52:1145-1149.
20. Cobby J, Mayersohn M, and Walker GC. Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental. J Pharm Sci 1974; 63:732-737.
21. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, and Peppas NA. Drug/polymer matrix swelling and dissolution. Pharm Res 1988; 5:488-494.
22. Higuchi T, Connors KA. "Phase-solubility techniques" in advances in analytical chemistry and instrumentation. 3rd ed. New York, Reilly CN. 1965.
23. Chouksey R, Pandey H, Jain AK, Soni H, and Saraogi GK. Preparation and evaluation of the self emulsifying drug delivery system containing atorvastatin HMGCOA inhibiter. Int J Pharmacy Pharm Sci 2011; 3(1):147-152.
24. Mura P, Moyano JR, Gonzalez-Rodriguez ML, Rabasco-Alvarez AM, Cirri M, and Maestrelli F. Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev Ind Pharm 2005; 31:425-434.
25. Alatas F, Sundani NS, and Asyarie DS. Influence of PEG 4000 concentration dissolution rate of ketoprofen in solid dispersion system of ketoprofen-PEG 4000. Majalah Farmasi Indonesia 2006; 17(2):57-62.
26. Patil S, Sherikar A, Patil S, and Patil A. Improvement of physicochemical characteristics and dissolution profile of poorly water soluble drug: ketoprofen by solid dispersion technique. Int J Res Pharm Sci 2010; 1(4):450-453.
27. Craig DQM, and Newton JM. The dissolution of nortryptyline HCl from polyethylene glycol solid dispersions. Drug Dev Ind Pharm 1985; 11:697-724.
28. Okonogi S, and Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS Pharm Sci Tech 2006; 7(2):E52.